Peptide useful in immunomodulation

Details Peptide useful in immunomodulation Peptide useful in immunomodulation

2006-10-17

2006-10-17

Carlson, Karen Cochrane (Department: 1653)

Chemistry: molecular biology and microbiology

Vector, per se

C536S023100, C514S002600, C514S04400A, C530S300000

Reexamination Certificate

active

07122372

ABSTRACT:
The present invention provides peptides and polynucleotides, and their use for immunomodulation, immunotherapy and vaccine particularly for anti-cancer therapy, and for diagnosis purposes. The immunomodulatory effect includes induction of proliferation and activation of peripheral blood lymphocytes and induction of an anti-tumor effect upon administration of peptides of the invention to subjects suffering from cancer.

REFERENCES:
patent: 4457917 (1984-07-01), Schaller nee Kronmayer et al.
patent: 4900549 (1990-02-01), Devries et al.
patent: 5164372 (1992-11-01), Matsuo et al.
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5298246 (1994-03-01), Yano et al.
patent: 5354900 (1994-10-01), Matsuo et al.
patent: 5403484 (1995-04-01), Ladner et al.
patent: 5418219 (1995-05-01), Ueda
patent: 5439688 (1995-08-01), Orsolini et al.
patent: 5571698 (1996-11-01), Ladner et al.
patent: 5716637 (1998-02-01), Anselem et al.
patent: 5733877 (1998-03-01), Sato et al.
patent: 5736519 (1998-04-01), Deigin et al.
patent: 5747653 (1998-05-01), Huergo et al.
patent: 5837500 (1998-11-01), Ladner et al.
patent: 5877155 (1999-03-01), Miller et al.
patent: 5961970 (1999-10-01), Lowell et al.
patent: 6013264 (2000-01-01), Petre et al.
patent: 6306404 (2001-10-01), Laposta et al.
patent: 6372223 (2002-04-01), Kistner et al.
patent: 6406700 (2002-06-01), Srivastava
patent: WO 94/20127 (1994-09-01), None
patent: WO 95/11700 (1995-05-01), None
patent: WO 95/19783 (1995-07-01), None
patent: WO 95/20605 (1995-08-01), None
patent: WO 97/11715 (1997-04-01), None
patent: WO 00/06723 (2000-02-01), None
patent: WO 00/58363 (2000-10-01), None
GenCore amino acid database, Accession No. A72330, Jun. 11, 1999.
Hardy, B. et al., “Activation of human lymphocytes by a monoclonal antibody to B lymphoblastoid cells; molecular mass and distribution of binding protein,” Cancer Immunology Immunotheraphy, vol. 40, No. 6, 376-382 (1995).
Hardy, B. et al., “Selection of novel peptides-based cancer vaccines by BAT monoclonal antibody,” XP002370959, International Journal of Molecular Medicine, vol. 10, No. Supplement 1, 9. S46; 7th World Congress on Advances in Oncology and the 5th International Symposium on Molecular Medicine; Hersonissos, Crete, Greece; Oct. 10-12, 2002.
Raiter, A., “CD4+lymphocytes as a primary cellular target for BAT mAb stimulation,” International Immunology, vol. 12, No. 11, 1623-1628 (2000).

Affiliated with

Also associated with

Rating

Peptide useful in immunomodulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptide useful in immunomodulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide useful in immunomodulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3714791